Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery

Last updated: November 24, 2021
Sponsor: University Hospitals Cleveland Medical Center
Overall Status: Completed

Phase

3

Condition

Acute Pain

Chronic Pain

Pain

Treatment

N/A

Clinical Study ID

NCT04246554
STUDY20180985
  • Ages 18-89
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

  1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following ACL reconstruction surgery.

  2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the standard of care pain protocol will reduce postoperative opioid consumption following ACL reconstruction surgery.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients between 18 and 89 years old
  • Patients undergoing primary anterior cruciate ligament (ACL) reconstruction surgery

Exclusion

Exclusion Criteria:

  • Patients below age 18 or above age 89
  • Illiterate or non-English speaking individuals
  • Patients with contraindications to Ketorolac
  • History of chronic alcohol or drug abuse
  • Chronic use of psychotropic or analgesic drugs
  • Known peptic ulcer disease or bleeding diasthesis
  • Renal dysfunction (estimated glomerular filtration rate < 50 mL/min/1.73m2)
  • Breastfeeding women
  • Pregnant women

Study Design

Total Participants: 49
Study Start date:
May 21, 2019
Estimated Completion Date:
January 01, 2021

Connect with a study center

  • UH Cleveland Medical Center

    Cleveland, Ohio 44106
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.